Morgan Stanley’s Palvella Therapeutics, Inc. Common Stock PVLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.06M Buy
135,754
+125,847
+1,270% +$2.84M ﹤0.01% 4433
2025
Q1
$277K Buy
9,907
+9,816
+10,787% +$275K ﹤0.01% 5593
2024
Q4
$1.09K Hold
91
﹤0.01% 7262
2024
Q3
$1.51K Buy
91
+9
+11% +$149 ﹤0.01% 7177
2024
Q2
$805 Sell
82
-4
-5% -$39 ﹤0.01% 7179
2024
Q1
$1.26K Sell
86
-85
-50% -$1.24K ﹤0.01% 7143
2023
Q4
$2.5K Buy
171
+69
+68% +$1.01K ﹤0.01% 7109
2023
Q3
$2.44K Hold
102
﹤0.01% 7088
2023
Q2
$1.36K Sell
102
-274
-73% -$3.65K ﹤0.01% 7253
2023
Q1
$29.4K Sell
376
-2,347
-86% -$183K ﹤0.01% 6483
2022
Q4
$227K Sell
2,723
-11,731
-81% -$976K ﹤0.01% 5615
2022
Q3
$1.33M Sell
14,454
-151
-1% -$13.9K ﹤0.01% 4706
2022
Q2
$2.19M Sell
14,605
-441
-3% -$66K ﹤0.01% 4459
2022
Q1
$3.65M Sell
15,046
-2,110
-12% -$512K ﹤0.01% 4016
2021
Q4
$5.19M Sell
17,156
-4,558
-21% -$1.38M ﹤0.01% 3684
2021
Q3
$8.98M Buy
21,714
+764
+4% +$316K ﹤0.01% 3025
2021
Q2
$6.42M Buy
20,950
+10,710
+105% +$3.28M ﹤0.01% 3510
2021
Q1
$2.11M Sell
10,240
-447
-4% -$91.9K ﹤0.01% 4222
2020
Q4
$2.14M Buy
10,687
+8,834
+477% +$1.77M ﹤0.01% 4097
2020
Q3
$307K Buy
1,853
+1,039
+128% +$172K ﹤0.01% 4892
2020
Q2
$202K Sell
814
-4,189
-84% -$1.04M ﹤0.01% 5073
2020
Q1
$912K Sell
5,003
-5,137
-51% -$936K ﹤0.01% 4025
2019
Q4
$2.94M Buy
10,140
+6,977
+221% +$2.02M ﹤0.01% 3720
2019
Q3
$863K Buy
3,163
+2,854
+924% +$779K ﹤0.01% 4383
2019
Q2
$117K Sell
309
-25
-7% -$9.47K ﹤0.01% 5254
2019
Q1
$89K Sell
334
-1,020
-75% -$272K ﹤0.01% 5440
2018
Q4
$288K Sell
1,354
-270
-17% -$57.4K ﹤0.01% 5119
2018
Q3
$727K Buy
1,624
+45
+3% +$20.1K ﹤0.01% 4760
2018
Q2
$641K Sell
1,579
-10,937
-87% -$4.44M ﹤0.01% 4931
2018
Q1
$6.83M Buy
12,516
+9,181
+275% +$5.01M ﹤0.01% 2707
2017
Q4
$2.01M Buy
3,335
+557
+20% +$336K ﹤0.01% 4022
2017
Q3
$1.28M Sell
2,778
-504
-15% -$232K ﹤0.01% 4262
2017
Q2
$1.33M Buy
3,282
+883
+37% +$357K ﹤0.01% 4159
2017
Q1
$499K Buy
2,399
+122
+5% +$25.4K ﹤0.01% 4834
2016
Q4
$256K Buy
2,277
+1,348
+145% +$152K ﹤0.01% 5255
2016
Q3
$136K Buy
929
+928
+92,800% +$136K ﹤0.01% 5186
2016
Q2
$0 Buy
+1
New ﹤0.01% 6681